Home
Conditions
Mantle Cell Lymphoma

Clinical trial condition

Mantle Cell Lymphoma

Explore clinical trials studying Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

252 public trials 59 recruiting studies

Refine in advanced search Browse all conditions

Mantle Cell Lymphoma trial results

Active, not recruiting

Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma

NCT04783415

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma

NCT03282396

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies

NCT05665062

Conditions: CLL/SLL, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +17 more
Locations: City of Hope Duarte, California, United States

Roswell Park Buffalo, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Active, not recruiting

Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas

NCT06300528

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations: Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States

View Trial Details

Active, not recruiting

Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT01880567

Conditions: CCND1 Positive, CCND2 Positive, CCND3 Positive, +14 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma

NCT02339922

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, not recruiting

GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma

NCT06522386

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

NCT03872180

Conditions: CCND1 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Emory Saint Joseph's Hospital Atlanta, Georgia, United States

Emory Johns Creek Hospital Johns Creek, Georgia, United States

View Trial Details

Active, not recruiting

Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma

NCT05004064

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The Royal Bournemouth Hospital Bournemouth, United Kingdom

University Hospital of Wales Cardiff, United Kingdom

Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

St. Bartholomew's Hospital London, United Kingdom

View Trial Details

Active, not recruiting

A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

NCT05934838

Conditions: B-cell Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +14 more
Locations: Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States

View Trial Details

Mantle Cell Lymphoma

Mantle Cell Lymphoma trial results

Related conditions